Production (Stage)
Amicus Therapeutics, Inc.
FOLD
$6.22
-$0.04-0.64%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -29.37M | -56.11M | -104.69M | -119.54M | -147.07M |
| Total Depreciation and Amortization | 8.23M | 8.55M | 8.69M | 8.75M | 8.77M |
| Total Amortization of Deferred Charges | 2.34M | 2.26M | 2.20M | 2.35M | 2.48M |
| Total Other Non-Cash Items | 92.98M | 110.35M | 121.79M | 109.82M | 122.26M |
| Change in Net Operating Assets | -70.62M | -98.94M | -54.51M | -43.27M | -67.16M |
| Cash from Operations | 3.56M | -33.89M | -26.52M | -41.89M | -80.72M |
| Capital Expenditure | -1.95M | -3.55M | -5.00M | -6.21M | -7.31M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -39.00M | 2.99M | 871.00K | 3.57M | 76.66M |
| Cash from Investing | -40.96M | -560.00K | -4.13M | -2.63M | 69.35M |
| Total Debt Issued | -- | -- | 387.36M | 387.36M | 387.36M |
| Total Debt Repaid | -70.00K | -97.00K | -408.29M | -408.35M | -408.33M |
| Issuance of Common Stock | 23.89M | 27.24M | 57.52M | 76.56M | 101.65M |
| Repurchase of Common Stock | -17.09M | -22.03M | -22.76M | -22.32M | -21.84M |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -1.59M | -1.59M | -2.65M |
| Cash from Financing | 6.73M | 5.12M | 12.23M | 31.66M | 56.19M |
| Foreign Exchange rate Adjustments | 2.60M | -4.03M | -11.04M | 10.89M | 2.99M |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -28.06M | -33.36M | -29.45M | -1.98M | 47.81M |